Antisense oligonucleotides (ASOs) are designed to bind to specific mRNA transcripts, preventing their translation into proteins. This binding can lead to the degradation of the mRNA via enzymes like RNase H or block the ribosome from translating the mRNA. ASOs have been used to target genes involved in cancer cell survival, proliferation, and metastasis.
